Irlanda - inglés - HPRA (Health Products Regulatory Authority)

hospira uk ltd - fludarabine phosphate - pdr for soln inj/inf - 50 milligram

Israel - inglés - Ministry of Health

novartis israel ltd - fludarabine phosphate - concentrate for solution for injection / infusion - fludarabine phosphate 50 mg/dose - fludarabine - fludarabine - palliative treatment of patients with cll refractory to other therapy. treatment of less malignant non-hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. fludarabine is indicated for the initial treatment of patients with b- cell chronic lymphocytic leukaemia (cll) or after first line therapy, in patients with sufficient bone marrow reserves.

Estados Unidos - inglés - NLM (National Library of Medicine)

actavis pharma, inc. - fludarabine phosphate (unii: 1x9vk9o1sc) (fludarabine - unii:p2k93u8740) - fludarabine phosphate 25 mg in 1 ml - fludarabine phosphate injection, usp is indicated for the treatment of adult patients with b-cell chronic lymphocytic leukemia (cll) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen. the safety and effectiveness of fludarabine phosphate injection, usp in previously untreated or non-refractory patients with cll have not been established. none teratogenic effects: pregnancy category d. [see warnings and precautions (5.6)] based on its mechanism of action, fludarabine phosphate can cause fetal harm when administered to a pregnant woman. there are no adequate and well-controlled studies of fludarabine phosphate injection in pregnant women, in rats, repeated intravenous doses of fludarabine phosphate at 2.4 times and 7.2 times the recommended human intravenous dose (25 mg/m2 ) administered during organogenesis caused an increase in resorptions, skeletal and visceral malformations (cleft palate, exencephaly, and fetal vertebra

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - fludarabine phosphate - solution for injection - 25mg/1ml

Malta - inglés - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - fludarabine phosphate - concentrate for solution for infusion or injection - fludarabine phosphate 25 milligram(s)/millilitre - antineoplastic agents

Malta - inglés - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - fludarabine phosphate - powder for solution for injection/infusion - fludarabine phosphate 50 mg - antineoplastic agents

Australia - inglés - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - fludarabine phosphate -

Australia - inglés - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - fludarabine phosphate -

Canadá - inglés - Health Canada

agila jamp canada inc - fludarabine phosphate - solution - 25.0mg - fludarabine phosphate 25.0mg - antineoplastic agents

Australia - inglés - Department of Health (Therapeutic Goods Administration)

actavis australia pty ltd - fludarabine phosphate -